Abstract:Acute pancreatitis, an acute inflammatory injury of the pancreas, lacks a specific treatment. The circulatory protein renalase is produced by the kidney and other tissues and has potent anti-inflammatory and prosurvival properties. Recombinant renalase can reduce the severity of mild cerulein pancreatitis; the activity is contained in a conserved 20 aa renalase site (RP220). Here, we investigated the therapeutic effects of renalase on pancreatitis using two clinically relevant models of acute pancreatitis. The ability of peptides containing the RP220 site to reduce injury in a 1-day post-endoscopic retrograde cholangiopancreatography (ERCP) and a 2-day severe cerulein induced in mice was examined. The initial dose of renalase peptides was given either prophylactically (before) or therapeutically (after) the initiation of the disease. Samples were collected to determine early pancreatitis responses (tissue edema, plasma amylase, active zymogens) and later histologic tissue injury and inflammatory changes. In both preclinical models, renalase peptides significantly reduced histologic damage associated with pancreatitis, especially inflammation, necrosis, and overall injury. Quantifying inflammation using specific immunohistochemical markers demonstrated that renalase peptides significantly reduced overall bone marrow-derived inflammation and neutrophils and macrophage populations in both models. In the severe cerulein model, administering a renalase peptide with or without pretreatment significantly reduced injury. Pancreatitis and renalase peptide effects appeared to be the same in female and male mice. These studies suggest renalase peptides that retain the anti-inflammatory and prosurvival properties of recombinant renalase can reduce the severity of acute pancreatitis and might be attractive candidates for therapeutic development.NEW & NOTEWORTHY Renalase is a secretory protein. The prosurvival and anti-inflammatory effects of the whole molecule are contained in a 20 aa renalase site (RP220). Systemic treatment with peptides containing this renalase site reduced the severity of post-endoscopic retrograde cholangiopancreatography (ERCP) and severe cerulein pancreatitis in mouse models.

Recombinant Reg3 Alpha Protein Protects Against Experimental Acute Pancreatitis In Mice

Recombinant Reg3α Protein Protects Against Experimental Acute Pancreatitis in Mice

Recombinant Reg3α Prevents Islet β-Cell Apoptosis and Promotes β-Cell Regeneration

Reg4 Protects Against Acinar Cell Necrosis in Experimental Pancreatitis.

Pancreatic islet-specific overexpression of Reg3β protein induced the expression of pro-islet genes and protected the mice against streptozotocin-induced diabetes mellitus.

Protective Effects of HTD4010, a Reg3α/PAP-derived Peptide, in Mouse Model of Acute Pancreatitis Via Toll-Like Receptor 4 Pathway.

<i>Reg4</i> deficiency aggravates pancreatitis by increasing mitochondrial cell death and fibrosis

Reg4 deficiency aggravates pancreatitis by increasing mitochondrial cell death and fibrosis

Reg3g Promotes Pancreatic Carcinogenesis in a Murine Model of Chronic Pancreatitis

Renalase peptides reduce pancreatitis severity in mice

Ginsenoside Rg3 ameliorates acute pancreatitis by activating the NRF2/HO‑1‑mediated ferroptosis pathway

Advance in the Research of Regenerating Gene Protein

Reg4 Regulates Pancreatic Regeneration Following Pancreatitis Via Modulating the Notch Signaling

Involvement Of Thrombopoietin In Acinar Cell Necrosis In L-Arginine-Induced Acute Pancreatitis In Mice

REG3A/REG3B promotes acinar to ductal metaplasia through binding to EXTL3 and activating the RAS-RAF-MEK-ERK signaling pathway

Serum Amyloid A3 is Required for Caerulein-Induced Acute Pancreatitis Through Induction of RIP3-dependent Necroptosis.

Protection of recombinant human growth hormone on rat liver with severe acute pancreatitis

A Non-Human Primate Derived Anti-P-selectin Glycoprotein Ligand-1 Antibody Curtails Acute Pancreatitis by Alleviating the Inflammatory Responses

Recombinant Human Interleukin-1 Receptor Antagonist (Rhil-1Ra) Attenuates Caerulein-Induced Chronic Pancreatitis in Mice.

Hesperidin Alleviates Acute Necrotizing Pancreatitis by Activating SIRT1 - Molecular Docking, Molecular Dynamics Simulation, and Experimental Validation

Reg3g ameliorates Tacrolimus‐induced pancreatic β‐cell dysfunction by restoring mitochondrial function in murine models